BioCryst Pharmaceuticals Up 29.1% Since SmarTrend Uptrend Call (BCRX)
March 23, 2017 at 14:27 PM EDT
SmarTrend identified an Uptrend for BioCryst Pharmaceuticals (NASDAQ:BCRX) on March 1st, 2017 at $6.68. In approximately 3 weeks, BioCryst Pharmaceuticals has returned 29.06% as of today's recent price of...
